Comparing Eylea HD vs Vabysmo
| Eylea HD (aflibercept) | Vabysmo (faricimab) |
|
|---|
| Eylea HD (aflibercept) | Vabysmo (faricimab) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Macular Degeneration, Diabetic Retinopathy, Macular Edema Following Retinal Vein Occlusion, Macular Edema, Diabetic Macular Edema, Retinopathy of Prematurity. Eylea HD may also be used... View more |
Prescription only
Prescribed for Macular Degeneration, Diabetic Macular Edema, Macular Edema, Macular Edema Following Retinal Vein Occlusion. Vabysmo may also be used for purposes not listed in this medication guide. |
Related suggestions Macular Degeneration
Diabetic Macular Edema
Macular Edema
Macular Edema Following Retinal Vein Occlusion
|
|||||||||||||||
| More about Eylea HD (aflibercept) | More about Vabysmo (faricimab) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Eylea HD has an average rating of 7.5 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
Vabysmo has an average rating of 7.8 out of 10 from a total of 31 ratings on Drugs.com. 58% of reviewers reported a positive effect, while 6% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Eylea HD side effects |
View all Vabysmo side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Eylea HD prices |
View all Vabysmo prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other aflibercept brands include: Ahzantive, Enzeevu, Eylea, Opuviz, Pavblu, Yesafili |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
144 hours |
180 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
January 28, 2022 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.